Public disclosure of inside information according to article 17 MAR
Leverkusen, Germany (pta017/24.11.2016/09:30) - The Management Board of Biofrontera AG (FSE: B8F) has announced on October 31 2016 a resolution regarding the issue of up to 49,990 subordinate convertible debentures ("Debentures") in a total nominal amount of up to EUR 4,999,000 ("Convertible Bond"). The Debentures could be subscribed to at a subscription price of 100% of the nominal value of a Debenture in an amount of EUR 100.00 per Debenture until and including November 23, 2016.
As per today's analysis, the Convertible Bond was placed in full.
The Management Board
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
contact person: Investor & public relations
phone: +49 (0) 214 87 63 20
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate